KTSA: FDA approves emergency use of COVID-19 drug being tested in San Antonio

Dr. Thomas Patterson, chief of the Division of Infectious Diseases, explained the implications of the FDA fast-tracking emergency authorization of the new anti-viral drug, remdesivir.

Listen to the interview. 



Share This Article!
Article Categories: COVID-19 Media Coverage, In the News